Pegi Ahlin Grabnar
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Molecular Medicine top 5%
- Hydrogels: synthesis, properties, applications
Papers in
-
- Protein purification and stability 12
- Viral Infectious Diseases and Gene Expression in Insects 6
- Lipid Membrane Structure and Behavior 3
-
- Advanced Drug Delivery Systems 8
- Drug Solubulity and Delivery Systems 5
- Advancements in Transdermal Drug Delivery 4
- Co-authors
- Julijana Kristl (6 shared papers)Iztok Grabnar (5 shared papers)Odon Planinšek (5 shared papers)Alenka Zvonar Pobirk (2 shared papers)Nataša Poklar Ulrih (3 shared papers)Bojana Balanč (1 shared paper)Aleksandra Jovanović (1 shared paper)Viktor Nedović (1 shared paper)
In The Last Decade
Pegi Ahlin Grabnar
28 papers receiving 773 citations
Peers
Comparison fields: 5 of 104
- Pharmaceutical Science 227
- Molecular Medicine 141
- Biomaterials 194
- Food Science 101
- Molecular Biology 273
Countries citing papers authored by Pegi Ahlin Grabnar
This map shows the geographic impact of Pegi Ahlin Grabnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pegi Ahlin Grabnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pegi Ahlin Grabnar more than expected).
Fields of papers citing papers by Pegi Ahlin Grabnar
This network shows the impact of papers produced by Pegi Ahlin Grabnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pegi Ahlin Grabnar. The network helps show where Pegi Ahlin Grabnar may publish in the future.
Co-authors
The 25 scholars most cited alongside Pegi Ahlin Grabnar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 208 | |
| 2 | 2018 | 104 | |
| 3 | 2011 | 97 | |
| 4 | 2020 | 81 | |
| 5 | 2013 | 56 | |
| 6 | 2018 | 43 | |
| 7 | 2015 | 25 | |
| 8 | 2019 | 24 | |
| 9 | 2009 | 23 | |
| 10 | 2011 | 22 | |
| 11 | 2010 | 18 | |
| 12 | 2024 | 12 | |
| 13 | 2015 | 12 | |
| 14 | 2010 | 10 | |
| 15 | 2011 | 7 | |
| 16 | 2025 | 6 | |
| 17 | 2024 | 6 | |
| 18 | 2015 | 5 | |
| 19 | 2015 | 5 | |
| 20 | 2023 | 4 |
About Pegi Ahlin Grabnar
Pegi Ahlin Grabnar is a scholar working on Molecular Biology, Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging, Cell Biology and Organic Chemistry, having authored 29 papers that have together received 784 indexed citations. Recurring topics across this work include Protein purification and stability (12 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Advanced Drug Delivery Systems (8 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), Drug Solubulity and Delivery Systems (5 papers), Advancements in Transdermal Drug Delivery (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Lipid Membrane Structure and Behavior (3 papers). The work is most often cited by research in Pharmaceutical Science (227 citations), Molecular Medicine (141 citations), Biomaterials (194 citations), Food Science (101 citations) and Molecular Biology (273 citations). Pegi Ahlin Grabnar has collaborated with scholars based in Slovenia, Serbia and Italy. Frequent co-authors include Julijana Kristl, Iztok Grabnar, Odon Planinšek, Alenka Zvonar Pobirk, Nataša Poklar Ulrih, Bojana Balanč, Aleksandra Jovanović, Viktor Nedović, Ajda Ota and Branko Bugarski. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Drug Delivery Science and Technology, European Journal of Pharmaceutical Sciences, Journal of Microencapsulation and Acta Pharmaceutica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.